Screening for PreS specific binding ligands with a phage displayed peptides library

doi:10.3748/wjg.v11.i26.4018

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 26

This Article

(0)

(5309)

(6)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Viral Hepatitis

World J Gastroenterol. Jul 14, 2005; 11(26): 4018-4023
Published online Jul 14, 2005. doi: 10.3748/wjg.v11.i26.4018

Full Size Figure Download Figure

Figure 6 Virus capture assay. The phage pool (10¹¹ CFU) after each round of screening shows an increasing binding capacity to HBV virions in the culture medium of HepG2.2.15.

Citation: Deng Q, Zhuang M, Kong YY, Xie YH, Wang Y. Screening for PreS specific binding ligands with a phage displayed peptides library. World J Gastroenterol 2005; 11(26): 4018-4023
URL: https://www.wjgnet.com/1007-9327/full/v11/i26/4018.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i26.4018

Deng Q, Zhuang M, Kong YY, Xie YH, Wang Y. Screening for PreS specific binding ligands with a phage displayed peptides library. World J Gastroenterol 2005; 11(26): 4018-4023 [PMID: 15996026 DOI: 10.3748/wjg.v11.i26.4018]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.